Detalhe da pesquisa
1.
The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma.
Blood
; 143(2): 152-165, 2024 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37832030
2.
Motive and Opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements-an LLMPP study.
Blood
; 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38701426
3.
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma.
N Engl J Med
; 386(4): 351-363, 2022 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34904799
4.
Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population.
Blood
; 141(20): 2493-2507, 2023 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36302166
5.
Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial.
Blood
; 141(16): 1971-1981, 2023 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36626583
6.
CAR T cells as a second-line therapy for large B-cell lymphoma: a paradigm shift?
Blood
; 139(18): 2737-2746, 2022 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35240677
7.
Developing a classification of hematologic neoplasms in the era of precision medicine.
Blood
; 140(11): 1193-1199, 2022 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35834418
8.
Limited-stage diffuse large B-cell lymphoma.
Blood
; 139(6): 822-834, 2022 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34932795
9.
Polatuzumab vedotin plus bendamustine and rituximab or obinutuzumab in relapsed/refractory follicular lymphoma: a phase Ib/II study.
Haematologica
; 109(4): 1194-1205, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37767550
10.
TMTV-Net: fully automated total metabolic tumor volume segmentation in lymphoma PET/CT images - a multi-center generalizability analysis.
Eur J Nucl Med Mol Imaging
; 2024 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38326655
11.
Long-term results of PET-guided radiation in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP.
Blood
; 137(7): 929-938, 2021 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32871586
12.
The impact of MYC and BCL2 structural variants in tumors of DLBCL morphology and mechanisms of false-negative MYC IHC.
Blood
; 137(16): 2196-2208, 2021 04 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33120427
13.
Diffuse large B-cell lymphoma.
Hematol Oncol
; 2023 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37435781
14.
Utilization of real-world data in assessing treatment effectiveness for diffuse large B-cell lymphoma.
Am J Hematol
; 98(1): 180-192, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36251361
15.
Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study.
Lancet Oncol
; 23(8): 1055-1065, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35803286
16.
Clinicopathological characteristics and long-term outcomes of plasmablastic lymphoma in British Columbia.
Br J Haematol
; 199(2): 230-238, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35961783
17.
Outcomes of Hodgkin variant Richter transformation in chronic lymphocytic leukaemia and small lymphocytic lymphoma in British Columbia.
Br J Haematol
; 198(4): 684-692, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35567407
18.
Outcome of primary mediastinal large B-cell lymphoma using R-CHOP: impact of a PET-adapted approach.
Blood
; 136(24): 2803-2811, 2020 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32603413
19.
Total metabolic tumor volume as a survival predictor for patients with diffuse large B-cell lymphoma in the GOYA study.
Haematologica
; 107(7): 1633-1642, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407602
20.
Comparison of immunohistochemistry and gene expression profiling subtyping for diffuse large B-cell lymphoma in the phase III clinical trial of R-CHOP ± ibrutinib.
Br J Haematol
; 194(1): 83-91, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33942292